A Phase III, Single-Arm Study to Evaluate the Efficacy and Safety of Paclitaxel-Hyaluronic Acid Conjugate Administered Intravesically to Patients with BCG-Unresponsive Carcinoma in Situ of the Bladder With or Without Ta-T1 Papillary Disease (Orion-BC Study) Sunil Patel, M.D.